Collectively, these results indicate that the loss of TSC1 enhances cellular α2,6-sialylation, thereby suppressing apoptosis and promoting tumor cell survival, suggesting that TSC1-mediated regulation of sialylation plays a critical role in malignant progression. The gene discussed is TSC1; the disease is neoplasm.